Pfizer Inc., a pharmaceutical company, reported net income for fiscal 2016 of $7,215 million, retained earnings at the start of the year of $71,993 million and dividends of $7,448 million, and other transactions with shareholders that increased retained earnings during the year by $14 million. If there were no additional transactions during the year that affected retained earnings, what was the balance of retained earnings at the end of the year? A. $ 71,774 million B. $ 38,748 million C. $124,926 million D. $ 47,729 million E. There is not enough information to calculate the amount.